Oruka Therapeutics, Inc. Operating Expenses
Oruka Therapeutics, Inc. (ORKA) reported Operating Expenses of $50.11 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-10
- Oruka Therapeutics, Inc. operating expenses for the quarter ending 2026-06-30 was $50.11M, a 76.25% increase year-over-year.
- Oruka Therapeutics, Inc. operating expenses for the quarter ending 2026-03-31 was $36.43M, a 45.24% increase year-over-year.
- Oruka Therapeutics, Inc. operating expenses for the quarter ending 2025-12-31 was $34.43M.
- Oruka Therapeutics, Inc. operating expenses for the quarter ending 2025-09-30 was $34.10M, a 15.81% increase year-over-year.
- Oruka Therapeutics, Inc. operating expenses for fiscal 2025 was $122.05M.
- Oruka Therapeutics, Inc. operating expenses for fiscal 2023 was $7.30M, a 31.14% decline from fiscal 2022.
- Oruka Therapeutics, Inc. operating expenses for fiscal 2022 was $10.60M, a 45.20% decline from fiscal 2021.
- Oruka Therapeutics, Inc. operating expenses for fiscal 2021 was $19.34M, a 97.98% increase from fiscal 2020.
| Period end | Operating Expenses 2 month | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 5 month | Operating Expenses 6 month | Operating Expenses 8 month | Operating Expenses 9 month | Operating Expenses 11 month | Operating Expenses 12 month | Operating Expenses 114 month | Operating Expenses 117 month | Operating Expenses 120 month | Operating Expenses 123 month | Operating Expenses 126 month | Operating Expenses 129 month | Operating Expenses 132 month | Operating Expenses 135 month | Operating Expenses 138 month | Operating Expenses 141 month | Operating Expenses 144 month | Operating Expenses 147 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $50.11M 10-Q · filed 2026-08-10 | $86.54M 10-Q · filed 2026-08-10 | $120.97M derived: sum of 3 quarters · filed 2026-08-10 | $155.08M derived: sum of 4 quarters · filed 2026-08-10 | |||||||||||||||||
| 2026-03-31 | $36.43M 10-Q · filed 2026-05-13 | $70.86M derived: sum of 2 quarters · filed 2026-05-13 | $104.97M derived: sum of 3 quarters · filed 2026-05-13 | $133.40M derived: sum of 4 quarters · filed 2026-08-10 | |||||||||||||||||
| 2025-12-31 | $34.43M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $68.54M derived: sum of 2 quarters · filed 2026-03-12 | $96.97M derived: sum of 3 quarters · filed 2026-08-10 | $122.05M 10-K · filed 2026-03-12 | |||||||||||||||||
| 2025-09-30 | $34.10M 10-Q · filed 2025-11-12 | $62.53M derived: sum of 2 quarters · filed 2026-08-10 | $87.62M 10-Q · filed 2025-11-12 | ||||||||||||||||||
| 2025-06-30 | $28.43M 10-Q · filed 2026-08-10 | $53.52M 10-Q · filed 2026-08-10 | |||||||||||||||||||
| 2025-03-31 | $25.09M 10-Q · filed 2026-05-13 | ||||||||||||||||||||
| 2024-12-31 | $88.12M 10-K · filed 2026-03-12 | ||||||||||||||||||||
| 2024-09-30 | $29.45M 10-Q · filed 2025-11-12 | $50.94M derived: sum of 2 quarters · filed 2025-11-12 | $57.80M 10-Q · filed 2025-11-12 | $53.42M derived: sum of 3 quarters · filed 2025-11-12 | $55.01M derived: sum of 4 quarters · filed 2025-11-12 | ||||||||||||||||
| 2024-06-30 | $21.49M 10-Q · filed 2025-08-11 | $3.12M 10-Q · filed 2024-08-01 | $28.36M 10-Q · filed 2025-08-11 | $5.60M 10-Q · filed 2024-08-01 | $25.57M derived: sum of 3 quarters · filed 2025-08-11 | $27.50M derived: sum of 4 quarters · filed 2025-08-11 | |||||||||||||||
| 2024-03-31 | $6.86M 10-Q · filed 2025-05-14 | $2.48M 10-Q · filed 2024-04-25 | $4.07M derived: sum of 2 quarters · filed 2024-04-25 | $6.01M derived: sum of 3 quarters · filed 2024-04-25 | $7.98M derived: sum of 4 quarters · filed 2024-08-01 | ||||||||||||||||
| 2023-12-31 | $1.59M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-01 | $3.53M derived: sum of 2 quarters · filed 2024-02-01 | $5.50M derived: sum of 3 quarters · filed 2024-08-01 | $7.30M 10-K · filed 2024-02-01 | |||||||||||||||||
| 2023-09-30 | $1.94M 10-Q · filed 2023-10-18 | $3.91M derived: sum of 2 quarters · filed 2024-08-01 | $5.71M 10-Q · filed 2023-10-18 | $7.25M derived: sum of 4 quarters · filed 2024-08-01 | |||||||||||||||||
| 2023-06-30 | $1.97M 10-Q · filed 2024-08-01 | $3.77M 10-Q · filed 2024-08-01 | $5.32M derived: sum of 3 quarters · filed 2024-08-01 | $7.87M derived: sum of 4 quarters · filed 2024-08-01 | |||||||||||||||||
| 2023-03-31 | $1.80M 10-Q · filed 2024-04-25 | $3.34M derived: sum of 2 quarters · filed 2024-04-25 | $5.90M derived: sum of 3 quarters · filed 2024-04-25 | $9.12M derived: sum of 4 quarters · filed 2024-04-25 | |||||||||||||||||
| 2022-12-31 | $1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-01 | $4.10M derived: sum of 2 quarters · filed 2024-02-01 | $7.32M derived: sum of 3 quarters · filed 2024-02-01 | $10.60M 10-K · filed 2024-02-01 | |||||||||||||||||
| 2022-09-30 | $2.55M 10-Q · filed 2023-10-18 | $5.77M derived: sum of 2 quarters · filed 2023-10-18 | $9.05M 10-Q · filed 2023-10-18 | $14.73M derived: sum of 4 quarters · filed 2023-10-18 | |||||||||||||||||
| 2022-06-30 | $3.22M 10-Q · filed 2023-07-21 | $6.50M 10-Q · filed 2023-07-21 | $12.18M derived: sum of 3 quarters · filed 2023-07-21 | $16.89M derived: sum of 4 quarters · filed 2023-07-21 | |||||||||||||||||
| 2022-03-31 | $3.28M 10-Q · filed 2023-04-24 | $8.96M derived: sum of 2 quarters · filed 2023-04-24 | $13.67M derived: sum of 3 quarters · filed 2023-04-24 | $18.51M derived: sum of 4 quarters · filed 2023-04-24 | |||||||||||||||||
| 2021-12-31 | $5.68M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24 | $10.40M derived: sum of 2 quarters · filed 2023-02-24 | $15.23M derived: sum of 3 quarters · filed 2023-02-24 | $19.34M 10-K · filed 2023-02-24 | |||||||||||||||||
| 2021-09-30 | $4.72M 10-Q · filed 2022-10-28 | $9.55M derived: sum of 2 quarters · filed 2022-10-28 | $13.65M 10-Q · filed 2022-10-28 | $18.78M derived: sum of 4 quarters · filed 2022-10-28 | |||||||||||||||||
| 2021-06-30 | $4.84M 10-Q · filed 2022-08-02 | $8.94M 10-Q · filed 2022-08-02 | $14.06M derived: sum of 3 quarters · filed 2022-08-02 | $16.05M derived: sum of 4 quarters · filed 2022-08-02 | |||||||||||||||||
| 2021-03-31 | $4.10M 10-Q · filed 2022-05-02 | $9.23M derived: sum of 2 quarters · filed 2022-05-02 | $11.22M derived: sum of 3 quarters · filed 2022-05-02 | $12.53M derived: sum of 4 quarters · filed 2022-05-02 | |||||||||||||||||
| 2020-12-31 | $5.13M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $7.12M derived: sum of 2 quarters · filed 2022-03-14 | $8.43M derived: sum of 3 quarters · filed 2022-03-14 | $9.77M 10-K · filed 2022-03-14 | |||||||||||||||||
| 2020-09-30 | $1.99M 10-Q · filed 2021-11-02 | $3.30M derived: sum of 2 quarters · filed 2021-11-02 | $4.64M 10-Q · filed 2021-11-02 | $5.92M derived: sum of 4 quarters · filed 2021-11-02 | |||||||||||||||||
| 2020-06-30 | $1.31M 10-Q · filed 2021-08-04 | $2.65M 10-Q · filed 2021-08-04 | $3.93M derived: sum of 3 quarters · filed 2021-08-04 | $5.17M derived: sum of 4 quarters · filed 2021-08-04 | |||||||||||||||||
| 2020-03-31 | $1.34M 10-Q · filed 2021-05-11 | $2.62M derived: sum of 2 quarters · filed 2021-05-11 | $3.87M derived: sum of 3 quarters · filed 2021-05-11 | $5.37M derived: sum of 4 quarters · filed 2021-05-11 | |||||||||||||||||
| 2019-12-31 | $1.28M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $2.52M derived: sum of 2 quarters · filed 2021-03-18 | $4.03M derived: sum of 3 quarters · filed 2021-03-18 | $5.81M 10-K · filed 2021-03-18 | |||||||||||||||||
| 2019-09-30 | $1.25M 10-Q · filed 2020-11-02 | $2.75M derived: sum of 2 quarters · filed 2020-11-02 | $4.54M 10-Q · filed 2020-11-02 | $6.06M derived: sum of 4 quarters · filed 2020-11-02 | |||||||||||||||||
| 2019-06-30 | $1.51M 10-Q · filed 2020-08-05 | $3.29M 10-Q · filed 2020-08-05 | $4.82M derived: sum of 3 quarters · filed 2020-08-05 | $6.48M derived: sum of 4 quarters · filed 2020-08-05 | |||||||||||||||||
| 2019-03-31 | $1.78M 10-Q · filed 2020-05-06 | $3.31M derived: sum of 2 quarters · filed 2020-05-06 | $4.97M derived: sum of 3 quarters · filed 2020-05-06 | $7.13M derived: sum of 4 quarters · filed 2020-05-06 | |||||||||||||||||
| 2018-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-18 | $3.19M derived: sum of 2 quarters · filed 2020-02-18 | $5.34M derived: sum of 3 quarters · filed 2020-02-18 | $8.12M 10-K · filed 2020-02-18 | |||||||||||||||||
| 2018-09-30 | $1.66M 10-Q · filed 2019-11-06 | $3.82M derived: sum of 2 quarters · filed 2019-11-06 | $6.59M 10-Q · filed 2019-11-06 | $10.89M derived: sum of 4 quarters · filed 2019-11-06 | |||||||||||||||||
| 2018-06-30 | $2.16M 10-Q · filed 2019-08-01 | $4.93M 10-Q · filed 2019-08-01 | $9.23M derived: sum of 3 quarters · filed 2019-08-01 | $13.70M derived: sum of 4 quarters · filed 2019-08-01 | |||||||||||||||||
| 2018-03-31 | $2.77M 10-Q · filed 2019-05-08 | $7.07M derived: sum of 2 quarters · filed 2019-05-08 | $11.54M derived: sum of 3 quarters · filed 2019-05-08 | $17.10M derived: sum of 4 quarters · filed 2019-05-08 | |||||||||||||||||
| 2017-12-31 | $4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $8.77M derived: sum of 2 quarters · filed 2019-02-27 | $14.33M derived: sum of 3 quarters · filed 2019-02-27 | $18.71M 10-K · filed 2019-02-27 | |||||||||||||||||
| 2017-09-30 | $4.47M 10-Q · filed 2018-11-14 | $10.03M derived: sum of 2 quarters · filed 2018-11-14 | $14.41M 10-Q · filed 2018-11-14 | $18.71M derived: sum of 4 quarters · filed 2018-11-14 | |||||||||||||||||
| 2017-06-30 | $5.56M 10-Q · filed 2018-08-09 | $9.94M 10-Q · filed 2018-08-09 | $14.23M derived: sum of 3 quarters · filed 2018-08-09 | $18.94M derived: sum of 4 quarters · filed 2018-08-09 | |||||||||||||||||
| 2017-03-31 | $4.38M 10-Q · filed 2018-05-08 | $8.67M derived: sum of 2 quarters · filed 2018-05-08 | $13.38M derived: sum of 3 quarters · filed 2018-05-08 | $17.33M derived: sum of 4 quarters · filed 2018-05-08 | |||||||||||||||||
| 2016-12-31 | $4.29M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | $9.00M derived: sum of 2 quarters · filed 2018-03-22 | $12.95M derived: sum of 3 quarters · filed 2018-03-22 | $16.61M 10-K · filed 2018-03-22 | |||||||||||||||||
| 2016-09-30 | $4.71M 10-Q · filed 2017-11-09 | $8.65M derived: sum of 2 quarters · filed 2017-11-09 | $12.32M 10-Q · filed 2017-11-09 | $15.50M derived: sum of 4 quarters · filed 2017-11-09 | |||||||||||||||||
| 2016-06-30 | $3.94M 10-Q · filed 2017-08-03 | $7.61M 10-Q · filed 2017-08-03 | $10.78M derived: sum of 3 quarters · filed 2017-08-03 | $13.60M derived: sum of 4 quarters · filed 2017-08-03 | |||||||||||||||||
| 2016-03-31 | $3.67M 10-Q · filed 2017-05-15 | $6.84M derived: sum of 2 quarters · filed 2017-05-15 | $9.66M derived: sum of 3 quarters · filed 2017-05-15 | $12.38M derived: sum of 4 quarters · filed 2017-05-15 | |||||||||||||||||
| 2015-12-31 | $3.17M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-21 | $5.99M derived: sum of 2 quarters · filed 2017-03-21 | $8.71M derived: sum of 3 quarters · filed 2017-03-21 | $11.46M 10-K · filed 2017-03-21 | |||||||||||||||||
| 2015-09-30 | $2.82M 10-Q · filed 2016-11-14 | $5.54M derived: sum of 2 quarters · filed 2016-11-14 | $8.28M 10-Q · filed 2016-11-14 | $10.89M derived: sum of 4 quarters · filed 2016-11-14 | |||||||||||||||||
| 2015-06-30 | $2.72M 10-Q · filed 2016-08-09 | $5.46M 10-Q · filed 2016-08-09 | $8.07M derived: sum of 3 quarters · filed 2016-08-09 | $10.36M derived: sum of 4 quarters · filed 2016-08-09 | |||||||||||||||||
| 2015-03-31 | $2.74M 10-Q · filed 2016-05-11 | $5.36M derived: sum of 2 quarters · filed 2016-05-11 | $7.64M derived: sum of 3 quarters · filed 2016-05-11 | $10.05M derived: sum of 4 quarters · filed 2016-05-11 | |||||||||||||||||
| 2014-12-31 | $2.61M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-17 | $4.90M derived: sum of 2 quarters · filed 2016-03-17 | $7.30M derived: sum of 3 quarters · filed 2016-03-17 | $9.69M 10-K · filed 2016-03-17 | |||||||||||||||||
| 2014-09-30 | $2.29M 10-Q · filed 2015-11-12 | $4.69M derived: sum of 2 quarters · filed 2015-11-12 | $7.08M 10-Q · filed 2015-11-12 | $10.03M derived: sum of 4 quarters · filed 2015-11-12 | |||||||||||||||||
| 2014-06-30 | $2.41M 10-Q · filed 2014-08-13 | $4.80M 10-Q · filed 2014-08-13 | $7.74M derived: sum of 3 quarters · filed 2014-08-13 | $9.47M derived: sum of 4 quarters · filed 2014-11-12 | |||||||||||||||||
| 2014-03-31 | $2.39M 10-Q · filed 2014-05-13 | $5.34M derived: sum of 2 quarters · filed 2014-05-13 | $7.06M derived: sum of 3 quarters · filed 2014-11-12 | $8.26M derived: sum of 4 quarters · filed 2014-11-12 | $108.47M 10-Q · filed 2014-05-13 | ||||||||||||||||
| 2013-12-31 | $2.95M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | $4.67M derived: sum of 2 quarters · filed 2014-11-12 | $5.87M derived: sum of 3 quarters · filed 2014-11-12 | $6.94M 10-K · filed 2014-03-20 | $106.08M 10-K · filed 2014-03-20 | ||||||||||||||||
| 2013-09-30 | $1.73M 10-Q · filed 2014-11-12 | $2.92M derived: sum of 2 quarters · filed 2014-11-12 | $3.99M 10-Q · filed 2014-11-12 | $4.83M derived: sum of 4 quarters · filed 2014-11-12 | $103.14M 10-Q · filed 2013-11-13 | ||||||||||||||||
| 2013-06-30 | $1.20M 10-Q · filed 2014-08-13 | $2.27M 10-Q · filed 2014-08-13 | $3.11M derived: sum of 3 quarters · filed 2014-08-13 | $4.04M derived: sum of 4 quarters · filed 2014-08-13 | $101.41M 10-Q · filed 2013-08-13 | ||||||||||||||||
| 2013-03-31 | $1.07M 10-Q · filed 2014-05-13 | $1.91M derived: sum of 2 quarters · filed 2014-05-13 | $2.84M derived: sum of 3 quarters · filed 2014-05-13 | $3.98M derived: sum of 4 quarters · filed 2014-05-13 | $100.21M 10-Q · filed 2013-05-13 | ||||||||||||||||
| 2012-12-31 | $839.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-20 | $1.77M derived: sum of 2 quarters · filed 2014-03-20 | $2.91M derived: sum of 3 quarters · filed 2014-03-20 | $4.32M 10-K · filed 2014-03-20 | $99.14M 10-K · filed 2013-03-21 | ||||||||||||||||
| 2012-09-30 | $928.00K 10-Q · filed 2013-11-13 | $2.07M derived: sum of 2 quarters · filed 2013-11-13 | $3.48M 10-Q · filed 2013-11-13 | $5.11M derived: sum of 4 quarters · filed 2013-11-13 | $98.30M 10-Q · filed 2012-11-13 | ||||||||||||||||
| 2012-06-30 | $1.15M 10-Q · filed 2013-08-13 | $2.55M 10-Q · filed 2013-08-13 | $4.18M derived: sum of 3 quarters · filed 2013-08-13 | $6.01M derived: sum of 4 quarters · filed 2013-08-13 | $97.38M 10-Q · filed 2012-08-13 | ||||||||||||||||
| 2012-03-31 | $1.41M 10-Q · filed 2013-05-13 | $3.04M derived: sum of 2 quarters · filed 2013-05-13 | $4.86M derived: sum of 3 quarters · filed 2013-05-13 | $6.57M derived: sum of 4 quarters · filed 2013-05-13 | $96.23M 10-Q · filed 2012-05-14 | ||||||||||||||||
| 2011-12-31 | $1.63M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-21 | $3.46M derived: sum of 2 quarters · filed 2013-03-21 | $5.16M derived: sum of 3 quarters · filed 2013-03-21 | $7.36M 10-K · filed 2013-03-21 | $94.82M 10-K · filed 2012-03-27 | ||||||||||||||||
| 2011-09-30 | $1.82M 10-Q · filed 2012-11-13 | $3.52M derived: sum of 2 quarters · filed 2012-11-13 | $5.73M 10-Q · filed 2012-11-13 | $8.08M derived: sum of 4 quarters · filed 2012-11-13 | $93.19M 10-Q · filed 2011-11-14 | ||||||||||||||||
| 2011-06-30 | $1.70M 10-Q · filed 2012-08-13 | $3.91M 10-Q · filed 2012-08-13 | $6.26M derived: sum of 3 quarters · filed 2012-08-13 | $8.36M derived: sum of 4 quarters · filed 2012-08-13 | $91.37M 10-Q · filed 2011-08-15 | ||||||||||||||||
| 2011-03-31 | $2.20M 10-Q · filed 2012-05-14 | $4.55M derived: sum of 2 quarters · filed 2012-05-14 | $6.66M derived: sum of 3 quarters · filed 2012-05-14 | $8.93M derived: sum of 4 quarters · filed 2012-05-14 | |||||||||||||||||
| 2010-12-31 | $2.35M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-27 | $4.46M derived: sum of 2 quarters · filed 2012-03-27 | $6.73M derived: sum of 3 quarters · filed 2012-03-27 | $9.18M 10-K · filed 2012-03-27 | |||||||||||||||||
| 2010-09-30 | $2.11M 10-Q · filed 2011-11-14 | $4.38M derived: sum of 2 quarters · filed 2011-11-14 | $6.82M 10-Q · filed 2011-11-14 | ||||||||||||||||||
| 2010-06-30 | $2.27M 10-Q · filed 2011-08-15 | $4.72M 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |